Cell and Gene Therapy Clinical Trials Market 2025 to 2034
Cell and Gene Therapy Clinical Trials Market 2025 to 2034
Cell and Gene Therapy Clinical Trials Market (By Phase: Phase I, Phase II, Phase III, Phase IV; By Indication: Oncology, Cardiology, CNS, Musculoskeletal, Infectious Diseases, Dermatology, Endocrine, Metabolic, Genetic, Immunology & Inflammation, Ophthalmology, Hematology, Gastroenterology, Others; By Region: North America, Latin America, Europe, Asia-Pacific, Middle and East Africa) Industry Size, Share, Growth, Trends 2025 to 2034.
Customisation Request
Revenue, 2025
USD 15.33 Bn
Forecast Year, 2034
USD 54.29 Bn
CAGR, 2025 - 2034
15.09%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global cell and gene therapy clinical trials market, valued at USD 15.33 billion in 2025, is projected to reach USD 54.29 billion by 2034, growing at a CAGR of 15.09%, driven by advances in personalized medicine and therapeutic innovations.
Cell and Gene Therapy Clinical Trials Market Size Analysis
Cell and Gene Therapy Clinical Trials Market Size By Phase 2025 to 2034 (USD Billion)
| Phase | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase I | 3.83 | 4.43 | 5.18 | 5.94 | 7.14 | 8.14 | 8.80 | 9.71 | 11.35 | 13.20 |
| Phase II | 5.37 | 5.97 | 6.94 | 7.82 | 8.84 | 10.44 | 12.11 | 14.03 | 15.92 | 18.33 |
| Phase III | 4.60 | 5.25 | 5.94 | 7.04 | 7.95 | 8.70 | 9.87 | 11.02 | 12.69 | 13.64 |
| Phase IV | 1.53 | 1.99 | 2.25 | 2.57 | 2.97 | 3.66 | 4.85 | 6.23 | 7.23 | 9.14 |
Cell and Gene Therapy Clinical Trials Market Size By Indication 2025 to 2034 (USD Billion)
| Indication | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 5.36 | 5.54 | 5.78 | 6.16 | 6.64 | 6.80 | 7.48 | 8.01 | 8.81 | 8.96 |
| Cardiology | 1.23 | 1.38 | 1.64 | 1.82 | 2.05 | 2.67 | 2.90 | 3.20 | 3.98 | 4.53 |
| CNS | 1.07 | 1.33 | 1.57 | 1.92 | 2.19 | 2.34 | 2.68 | 3.18 | 3.31 | 4.05 |
| Musculoskeletal | 0.92 | 1.02 | 1.17 | 1.61 | 1.79 | 2.13 | 2.41 | 2.52 | 3.29 | 4.27 |
| Infectious Diseases | 1.07 | 1.12 | 1.19 | 1.47 | 1.54 | 2.00 | 2.66 | 2.98 | 3.38 | 3.53 |
| Dermatology | 0.77 | 0.99 | 1.12 | 1.33 | 1.72 | 2.07 | 2.36 | 3.13 | 3.94 | 4.54 |
| Endocrine, Metabolic, Genetic | 0.92 | 1.16 | 1.37 | 1.64 | 1.79 | 2.21 | 2.81 | 3.39 | 4.21 | 4.60 |
| Immunology & Inflammation | 1.23 | 1.32 | 1.66 | 2.10 | 2.57 | 2.61 | 2.98 | 3.76 | 4.41 | 5.14 |
| Ophthalmology | 0.77 | 1.12 | 1.45 | 1.49 | 1.81 | 2.12 | 2.32 | 2.51 | 2.69 | 3.37 |
| Hematology | 1.23 | 1.58 | 1.66 | 1.81 | 2.31 | 2.47 | 2.65 | 2.98 | 3.45 | 4.02 |
| Gastroenterology | 0.46 | 0.56 | 0.91 | 1.01 | 1.30 | 1.74 | 2.17 | 2.76 | 2.91 | 3.48 |
| Others | 0.31 | 0.53 | 0.78 | 1.00 | 1.19 | 1.80 | 2.21 | 2.57 | 2.81 | 3.83 |
Cell and Gene Therapy Clinical Trials Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 6.13 | 6.88 | 7.55 | 8.58 | 9.71 | 10.88 | 12.71 | 13.70 | 15.86 | 16.77 |
| Europe | 3.83 | 4.32 | 5.11 | 5.87 | 6.40 | 7.12 | 7.79 | 9.34 | 10.59 | 12.37 |
| Asia Pacific | 3.07 | 3.36 | 4.01 | 4.74 | 5.28 | 6.38 | 7.11 | 7.96 | 9.17 | 11.01 |
| Latin America | 1.53 | 2.01 | 2.39 | 2.67 | 3.47 | 4.17 | 4.90 | 6.00 | 7.02 | 8.54 |
| Middle East and Africa | 0.77 | 1.07 | 1.25 | 1.51 | 2.05 | 2.40 | 3.12 | 4.00 | 4.55 | 5.62 |
Cell and Gene Therapy Clinical Trials Market Size to Lead USD 54.29 Billion by 2034
The global cell and gene therapy clinical trials market size accounted for USD 15.33 billion in 2025 and is predicted to touch around USD 54.29 billion by 2034 a CAGR of 15.09%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
